Trial Profile
A multicenter, randomized, open, parallel, prospective study to investigate the effectiveness of 50mg gemigliptin on diabetic retinopathy in patients with type 2 diabetes
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2020
Price :
$35
*
At a glance
- Drugs Gemigliptin (Primary) ; Gliclazide; Glimepiride; Insulin; Metformin
- Indications Diabetic retinopathy; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Zemi-DR
- 15 Jun 2018 New trial record